Received Jun 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X024966 | OT |
Confirmed no symptomatic adverse events reported; that an expired dose of VAQTA was inadvertently administered to a patient; This spontaneous report was received from a medical Assistant who is a Clinical supervisor and refers to a 50-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-Jun-2025, the patient was vaccinated with Hepatitis A Vaccine, Inactivated (VAQTA), (lot #X024966, expiration date: 23-Mar-2025) administered by Unknown route for prophylaxis (Expired product administered). Caller also added that the patient was receiving Hepatitis A Vaccine, Inactivated (VAQTA) because she was going to be traveling out of country. Confirmed no symptomatic adverse events reported. No additional AE. No PQC.